ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

In Brief: Heavy Smokers More Resistant To Quitting,

March 10, 1995

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993